4.68
price down icon2.30%   -0.11
after-market アフターアワーズ: 4.67 -0.010 -0.21%
loading
前日終値:
$4.79
開ける:
$4.82
24時間の取引高:
787.97K
Relative Volume:
1.00
時価総額:
$193.74M
収益:
$134.48M
当期純損益:
$-38.94M
株価収益率:
-4.9087
EPS:
-0.9534
ネットキャッシュフロー:
$-19.34M
1週間 パフォーマンス:
-4.68%
1か月 パフォーマンス:
-17.61%
6か月 パフォーマンス:
-63.32%
1年 パフォーマンス:
-66.78%
1日の値動き範囲:
Value
$4.66
$4.86
1週間の範囲:
Value
$4.48
$4.97
52週間の値動き範囲:
Value
$4.48
$14.29

Rxsight Inc Stock (RXST) Company Profile

Name
名前
Rxsight Inc
Name
セクター
Healthcare (1107)
Name
電話
949-521-7822
Name
住所
100 COLUMBIA STREET, ALISO VIEJO
Name
職員
461
Name
Twitter
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
RXST's Discussions on Twitter

Compare RXST vs ABT, SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RXST icon
RXST
Rxsight Inc
4.68 198.29M 134.48M -38.94M -19.34M -0.9534
ABT icon
ABT
Abbott Laboratories
90.62 154.45B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
310.58 118.05B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
81.32 103.20B 36.36B 4.84B 5.43B 3.7212
BSX icon
BSX
Boston Scientific Corp
46.92 69.50B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
88.58 49.68B 6.30B 1.07B 1.09B 1.8406

Rxsight Inc Stock (RXST) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-30 開始されました William Blair Mkt Perform
2025-07-15 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-07-10 ダウングレード Jefferies Buy → Hold
2025-07-09 ダウングレード BTIG Research Buy → Neutral
2025-07-09 ダウングレード Oppenheimer Outperform → Perform
2025-07-09 ダウングレード Wells Fargo Overweight → Equal Weight
2025-05-19 アップグレード Wells Fargo Equal Weight → Overweight
2025-04-15 開始されました Piper Sandler Neutral
2025-04-09 ダウングレード UBS Buy → Neutral
2025-04-04 ダウングレード JP Morgan Overweight → Underweight
2025-04-03 ダウングレード BofA Securities Buy → Underperform
2024-12-20 ダウングレード Stifel Buy → Hold
2024-12-11 ダウングレード Wells Fargo Overweight → Equal Weight
2024-12-06 開始されました UBS Buy
2024-10-29 開始されました Jefferies Buy
2024-08-20 繰り返されました Needham Buy
2024-08-06 繰り返されました Needham Buy
2024-05-07 繰り返されました BTIG Research Buy
2023-12-13 アップグレード Wells Fargo Equal Weight → Overweight
2023-12-12 開始されました Stifel Buy
2023-12-04 開始されました Morgan Stanley Overweight
2023-04-13 開始されました Oppenheimer Outperform
2022-12-12 ダウングレード Wells Fargo Overweight → Equal Weight
2022-04-08 開始されました Needham Buy
すべてを表示

Rxsight Inc (RXST) 最新ニュース

pulisher
Jun 12, 2026

RxSight, Inc. Hits 52-Week Low of $4.58 Amidst 92.2% Decline - MarketsMojo

Jun 12, 2026
pulisher
Jun 12, 2026

RxSight, Inc. Stock Plummets to New 52-Week Low of $4.49 - Markets Mojo

Jun 12, 2026
pulisher
Jun 11, 2026

RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates - MSN

Jun 11, 2026
pulisher
Jun 07, 2026

RxSight Inc. (RXST) Falters Near Support: Testing Key Levels After 1.96% DeclineDark Pool Sentiment - newsline.com

Jun 07, 2026
pulisher
Jun 06, 2026

Understanding Momentum Shifts in (RXST) - Stock Traders Daily

Jun 06, 2026
pulisher
Jun 05, 2026

RxSight, Inc. Hits 52-Week Low at $5.31 Amid Ongoing Struggles - MarketsMojo

Jun 05, 2026
pulisher
Jun 05, 2026

RxSight, Inc. Hits 52-Week Low at USD 4.93 Amidst Ongoing Struggles - MarketsMojo

Jun 05, 2026
pulisher
Jun 03, 2026

RxSight Inc. (RXST) Slides 3% as Stock Struggles Below Key Resistance at $5.03Hedge Fund Exposure - newsline.com

Jun 03, 2026
pulisher
Jun 02, 2026

RxSight Inc. (RXST) Q1 2026 Earnings: EPS Miss Weighs on Shares Amid Operating ChallengesProfitability Analysis - newsline.com

Jun 02, 2026
pulisher
Jun 02, 2026

RXST Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 02, 2026
pulisher
May 31, 2026

RxSight Inc stock (US78419L1008): Nasdaq-listed eye-care specialist in focus after recent price weak - AD HOC NEWS

May 31, 2026
pulisher
May 31, 2026

RXST Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock DeclinesEarnings Call Highlights - newsline.com

May 31, 2026
pulisher
May 29, 2026

RxSight Inc. (RXST) Slips 4.65% as Stock Challenges $5.06 Support LevelTICK Divergence - The Legal Advocate

May 29, 2026
pulisher
May 29, 2026

RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid - TipRanks

May 29, 2026
pulisher
May 28, 2026

RXST Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Ramp-UpEPS Growth Rate - The Legal Advocate

May 28, 2026
pulisher
May 27, 2026

Midday Stock Roundup: TTM Drops on Investor Day - Orange County Business Journal

May 27, 2026
pulisher
May 27, 2026

RxSight Must Litigate Investor Suit Over Eye Lens System Demand - Bloomberg Law News

May 27, 2026
pulisher
May 26, 2026

RXST: Premium IOL penetration grows as competitive headwinds ease and commercial focus intensifies - TradingView

May 26, 2026
pulisher
May 26, 2026

Avoiding Lag: Real-Time Signals in (RXST) Movement - Stock Traders Daily

May 26, 2026
pulisher
May 25, 2026

RxSight Inc. Q1 2026 Earnings: EPS Misses Estimates Amid Operational HeadwindsOne-Time Loss Impact - Newser

May 25, 2026
pulisher
May 23, 2026

RxSight Q1 2026 Earnings: EPS Misses Estimates by 32% as Operational Costs WeighEarnings Beat Streak - The Legal Advocate

May 23, 2026
pulisher
May 21, 2026

RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround - Bez Kabli

May 21, 2026
pulisher
May 19, 2026

RxSight to present at Stifel 2026 Virtual Ophthalmology Forum on May 26 - Pluang

May 19, 2026
pulisher
May 19, 2026

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum - The Manila Times

May 19, 2026
pulisher
May 19, 2026

RxSight stock (US78419L1008): Q1 revenue dip and share slide put growth story to the test - AD HOC NEWS

May 19, 2026
pulisher
May 18, 2026

Tarsus, RxSight Fall Despite Growth Signals - Orange County Business Journal

May 18, 2026
pulisher
May 17, 2026

RxSight stock (US78419L1008): FDA-linked growth and execution stay in focus - AD HOC NEWS

May 17, 2026
pulisher
May 16, 2026

RxSight stock (US78419L1008): FDA-backed growth story stays in focus - AD HOC NEWS

May 16, 2026
pulisher
May 16, 2026

Number of shareholders of RxSight, Inc. – NASDAQ:RXST - TradingView

May 16, 2026
pulisher
May 15, 2026

Discipline and Rules-Based Execution in RXST Response - Stock Traders Daily

May 15, 2026
pulisher
May 14, 2026

RxSight Earnings Call Balances Growth With Headwinds - TipRanks

May 14, 2026
pulisher
May 14, 2026

TradingKey - TradingKey

May 14, 2026
pulisher
May 14, 2026

BofA Securities Maintains RxSight(RXST.US) With Sell Rating - Moomoo

May 14, 2026
pulisher
May 13, 2026

RXST: Stable Q1 results and ongoing commercial initiatives support sequential growth and global expansion - TradingView

May 13, 2026
pulisher
May 13, 2026

Artisan Partners reports 5.0% stake in RxSight (NASDAQ: RXST) - Stock Titan

May 13, 2026
pulisher
May 12, 2026

Midday Stock Roundup: Skyworks Solutions Falls - Orange County Business Journal

May 12, 2026
pulisher
May 12, 2026

RxSight (RXST) Q1 2026 Earnings Transcript - AOL.com

May 12, 2026
pulisher
May 12, 2026

RxSight, Inc. (NASDAQ:RXST) Q1 2026 Earnings Call Transcript - Insider Monkey

May 12, 2026
pulisher
May 11, 2026

RxSight (RXST) Gets a Hold from Stifel Nicolaus - The Globe and Mail

May 11, 2026
pulisher
May 08, 2026

William Blair Maintains RxSight(RXST.US) With Hold Rating - Moomoo

May 08, 2026
pulisher
May 08, 2026

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook - VisionMonday.com

May 08, 2026
pulisher
May 07, 2026

Piper Sandler Maintains RxSight(RXST.US) With Hold Rating, Maintains Target Price $10 - Moomoo

May 07, 2026
pulisher
May 07, 2026

RxSight, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 07, 2026

Rxsight Inc (RXST) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rxsight Inc (RXST) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Goldshleger Ilya
See remarks
Sep 25 '25
Option Exercise
4.27
23,445
99,998
65,691
ZBH ZBH
$89.33
price up icon 1.21%
STE STE
$206.51
price up icon 0.28%
PHG PHG
$26.80
price up icon 0.41%
$73.16
price down icon 1.43%
$63.23
price down icon 2.36%
EW EW
$88.58
price up icon 2.67%
大文字化:     |  ボリューム (24 時間):